Algernon Pharmaceuticals (QB) Stock Price

-0.005728 (-2.66%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Algernon Pharmaceuticals Inc (QB) AGNPF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005728 -2.66% 0.21 16:32:54
Close Price Low Price High Price Open Price Previous Close
0.21 0.20 0.2199 0.21 0.215728
Bid Price Ask Price Spread News
0.2044 0.214 0.0096 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
65 176,232 $ 0.211093 $ 37,201 674,543 0.036 - 0.4867
Last Trade Time Type Quantity Stock Price Currency
15:55:09 3,238 $ 0.21 USD

Algernon Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 29.03M 138.24M 96.29M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
17.04k $ - 0.00% - -

more financials information »

Algernon Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGNPF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.18630.2550.18630.2211223161,7490.023712.72%
1 Month0.23010.25730.18630.2313034279,948-0.0201-8.74%
3 Months0.280.3140.1810.2506842633,782-0.07-25.0%
6 Months0.27460.48670.1330.2553564813,927-0.0646-23.53%
1 Year0.040.48670.0360.2445272667,4910.17425.0%
3 Years0.040.48670.0360.2445272667,4910.17425.0%
5 Years0.040.48670.0360.2445272667,4910.17425.0%

Algernon Pharmaceuticals (QB) Description

The company is a clinical stage pharmaceutical development company focused on the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). The company's key compounds were identified using a drug repurposing strategy.

Your Recent History
Algernon P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.